{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"","title":"Coronapod: Why T cells have been overlooked","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/61b9f3b71a8cbe675f3cedcb/620a5bdfbbc3134cb7121080.png?height=200","description":"Much of the coverage of COVID immunity often focuses on antibody response and for good reason - these small, y-shaped proteins can detect, and in some cases neutralise, viruses like SARS-CoV-2. But as variants like Omicron evolve to evade antibodies, the role of another part of the immune system, T cells, has been brought into sharper focus. These immune cells work in a different way to antibodies, attacking infected cells rather than the virus itself, which can make their response broader and more robust. Now, research is showing that, unlike antibodies, T cell potency is not impacted by the mutations in variants like Omicron. In this episode of Coronapod, we ask why T cells are so often overlooked, and what role they might be playing in our protection from the coronavirus.\n\n\nNews:‘Killer’ immune cells still recognize Omicron variant\n\n\nSubscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.","author_name":"Springer Nature Limited"}